I. Savickaite

Opportunities for Participation in Randomized Controlled Trials for Patients with Multiple Myeloma: Trial Access Depends on Restrictive Eligibility Criteria and Patient Expectations

U. Germing, G. Kobbe, R. Fenk, 2022, Cancers.

Therapy-related myeloid neoplasms following treatment for multiple myeloma—a single center analysis

U. Germing, G. Kobbe, R. Fenk, 2022, Annals of Hematology.

Efficacy and Tolerability of High- versus Low-dose Lenalidomide Maintenance Therapy of Multiple Myeloma after Autologous Blood Stem Cell Transplantation

H. Goldschmidt, G. Kobbe, R. Fenk, 2020, Clinical Cancer Research.

Favourable Outcome of Elderly Patients with Multiple Myeloma Treated with Tandem Melphalan 100 High-Dose Therapy, Autologous Stem Cell Transplantation and Novel Agents - a Single Center Experience

G. Kobbe, J. Neukirchen, R. Fenk, 2016 .